» Articles » PMID: 35237170

Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice-A Cross-Sectional Database Study

Overview
Journal Front Pharmacol
Date 2022 Mar 3
PMID 35237170
Authors
Affiliations
Soon will be listed here.
Abstract

The frequency of medication prescribing and polypharmacy has increased in recent years in different settings, including Swiss general practice. We aimed to describe patient age- and sex-specific rates of polypharmacy and of prescriptions of the most frequent medication classes, and to explore practitioner variability in prescribing. Retrospective cross-sectional study based on anonymized electronic medical records data of 111 811 adult patients presenting to 116 Swiss general practitioners in 2019. We used mixed-effects regression analyses to assess the association of patient age and sex with polypharmacy (≥5 medications) and with the prescription of specific medication classes (second level of the Anatomical Therapeutic Chemical Classification System). Practitioner variability was quantified in terms of the random effects distributions. The prevalence of polypharmacy increased with age from 6.4% among patients aged 18-40 years to 19.7% (41-64 years), 45.3% (65-80 years), and 64.6% (81-92 years), and was higher in women than in men, particularly at younger ages. The most frequently prescribed medication classes were (21.6% of patients), (19.9%), (18.7%), and (18.3%). Men were more often prescribed agents targeting the cardiovascular system, whereas most other medications were more often prescribed to women. The highest practitioner variabilities were observed for , for and for . Based on practitioner variability, prevalence, and risk potential, antiinflammatory drugs and polypharmacy in older patients appear to be the most pressing issues in current drug prescribing routines.

Citing Articles

The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in Austria.

Otter M, Kothgassner O, Lepuschutz L, Drahos S, Plener P Child Adolesc Psychiatry Ment Health. 2024; 18(1):10.

PMID: 38218981 PMC: 10788023. DOI: 10.1186/s13034-023-00684-x.


Ambient temperature and kidney function in primary care patients.

Schietzel S, Zechmann S, Valeri F, Staudinger M, Cippa P, Seibert J J Nephrol. 2023; 37(1):95-105.

PMID: 37610683 PMC: 10920449. DOI: 10.1007/s40620-023-01715-8.


Epidemiology and association with outcomes of polypharmacy in patients undergoing surgery: retrospective, population-based cohort study.

Jonsdottir F, Blondal A, Gudmundsson A, Bates I, Stevenson J, Sigurdsson M BJS Open. 2023; 7(3).

PMID: 37194458 PMC: 10189279. DOI: 10.1093/bjsopen/zrad041.


Quality and variation of care for chronic kidney disease in Swiss general practice: A retrospective database study.

Jager L, Rosemann T, Burgstaller J, Senn O, Markun S PLoS One. 2022; 17(8):e0272662.

PMID: 35951667 PMC: 9371276. DOI: 10.1371/journal.pone.0272662.

References
1.
Kongkaew C, Hann M, Mandal J, Williams S, Metcalfe D, Noyce P . Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy. 2013; 33(8):827-37. DOI: 10.1002/phar.1287. View

2.
Coyle R, Feher M, Jones S, Hamilton M, de Lusignan S . Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practice. PLoS One. 2019; 14(1):e0210657. PMC: 6328229. DOI: 10.1371/journal.pone.0210657. View

3.
Insani W, Whittlesea C, Alwafi H, Man K, Chapman S, Wei L . Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis. PLoS One. 2021; 16(5):e0252161. PMC: 8153435. DOI: 10.1371/journal.pone.0252161. View

4.
Meier R, Keizer E, Rosemann T, Markun S . Indications and associated factors for prescribing intravenous iron supplementation in Swiss general practice: a retrospective observational study. Swiss Med Wkly. 2019; 149:w20127. DOI: 10.4414/smw.2019.20127. View

5.
Schneider R, Reinau D, Schur N, Blozik E, Fruh M, Signorell A . Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data. Swiss Med Wkly. 2019; 149:w20126. DOI: 10.4414/smw.2019.20126. View